
Trifexis is an FDA-approved preparation containing Trifexis, for veterinary use. Available by prescription.
Spinosad and milbemycin oxime, commercially available as Trifexis, is a combination oral preventative utilized for canine parasite management. It is a prescription medication available for use in dogs, requiring a valid veterinarian-client-patient relationship. It is frequently considered in the context of parasite prevention for managing heartworms, fleas and intestinal worms.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, spinosad manages the nervous system of fleas while milbemycin is used in the context of managing the lifecycle of heartworms and specific intestinal parasites. Commonly observed effects include localized digestive changes such as vomiting or a temporary decrease in appetite. A significant clinical consideration is the requirement for a negative heartworm test before starting. Owners should monitor for any unusual behavioral shifts and contact their veterinarian promptly with any concerns.
Yes. Trifexis is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all legal requirements are met before dispensing.
Veterinarians discuss Trifexis for its ability to manage fleas, heartworms, hookworms, roundworms and whipworms. Its mechanism offers an approach to comprehensive monthly management.
Trifexis is absorbed and tolerated better when given with a full meal. Your veterinarian will provide specific guidance on the most appropriate administration schedule.
Veterinarians perform a test before authorizing preventative management to ensure no adult worms are present. Administering prevention to a positive dog may lead to severe clinical complications.
If vomiting occurs shortly after administration, you should contact your veterinarian. They will determine if a repeat dose is necessary to ensure the management approach remains appropriate.




